In Reply: Tumor Growth Rate as a New Predictor of Progression-Free Survival After Chordoma Surgery. Passeri T, di Russo P, Giammattei L, Froelich S, et al. Neurosurgery 2022;90:e20.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Passeri T, di Russo P, Giammattei L, Froelich S, et al. In Reply: Tumor Growth Rate as a New Predictor of Progression-Free Survival After Chordoma Surgery. Neurosurgery 2022;90:e20.
PMID: 34982892